Treatment
View as
NMDA-receptor antagonist
Memantine, an NMDA-receptor antagonist, is approved for the treatment of Alzheimer's disease (AD). Preliminary evidence suggests it is tolerated in FTD and may provide some benefit but a prospective trial is ongoing.